Lecanemab Offers New Hope in Alzheimer’s Fight, But NHS Access Remains Uncertain
A pioneering treatment for Alzheimer’s disease has renewed hopes of slowing the progression of the condition, following encouraging longer-term findings. However, despite receiving regulatory approval…
Read more...